
PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation
Volv Global is proud to be helping to organise the upcoming PCMG AI Symposium on AI in Clinical Trials, shaping
Volv Global is proud to be helping to organise the upcoming PCMG AI Symposium on AI in Clinical Trials, shaping
We’re gearing up for the World Orphan Drug Congress Europe 2025 with the theme: “Where technology meets Human” Volv Global
Volv Global CEO and Founder Christopher Rudolf will speak on optimising rare disease clinical trials with Real World Data at
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Recently, I had powerful thought come to me on reading
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Emerging artificial intelligence solutions offer promising strategies to address critical
By Léon Van Wouwe, Clinical Innovation Director, Volv Global New data from Roche’s Itovebi (inavolisib) combined with Pfizer’s Ibrance